219 related articles for article (PubMed ID: 20966430)
1. FDA to regulate direct-to-consumer genetic tests.
Brower V
J Natl Cancer Inst; 2010 Nov; 102(21):1610-2, 1617. PubMed ID: 20966430
[No Abstract] [Full Text] [Related]
2. Direct to confusion: lessons learned from marketing BRCA testing.
Matloff E; Caplan A
Am J Bioeth; 2008 Jun; 8(6):5-8. PubMed ID: 18726769
[TBL] [Abstract][Full Text] [Related]
3. Direct-to-Consumer Genetic Testing: The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing.
Gill J; Obley AJ; Prasad V
JAMA; 2018 Jun; 319(23):2377-2378. PubMed ID: 29800087
[No Abstract] [Full Text] [Related]
4. Consumer alert: ethical issues raised by the sale of genetic tests directly to consumers.
Wasson K
Am J Bioeth; 2008 Jun; 8(6):16-8. PubMed ID: 18726774
[No Abstract] [Full Text] [Related]
5. Making breast cancer risk assessment personal.
Vanchieri C
J Natl Cancer Inst; 2010 Jul; 102(13):924-6. PubMed ID: 20576931
[No Abstract] [Full Text] [Related]
6. Genes on the Web--direct-to-consumer marketing of genetic testing.
Wolfberg AJ
N Engl J Med; 2006 Aug; 355(6):543-5. PubMed ID: 16899772
[No Abstract] [Full Text] [Related]
7. FDA regulation of genetic testing: institutional reluctance and public guardianship.
Huang A
Food Drug Law J; 1998; 53(3):555-91. PubMed ID: 10346728
[No Abstract] [Full Text] [Related]
8. A public health perspective on the control of predictive screening for breast cancer.
Cunningham GC
Health Matrix Clevel; 1997; 7(1):31-48. PubMed ID: 10167177
[No Abstract] [Full Text] [Related]
9. Commercialization of genetic testing services: the FDA, market forces, and biological tarot cards.
Malinowski MJ; Blatt RJ
Tulane Law Rev; 1997 Mar; 71(4):1211-312. PubMed ID: 15744901
[TBL] [Abstract][Full Text] [Related]
10. US urged to monitor some genetic tests.
Wadman M
Nature; 1997 Feb; 385(6616):477. PubMed ID: 9020348
[No Abstract] [Full Text] [Related]
11. Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health.
Javitt GH; Stanley E; Hudson K
Oklahoma Law Rev; 2004; 57(2):251-302. PubMed ID: 15658034
[No Abstract] [Full Text] [Related]
12. Advertising genetic testing for breast cancer.
Weber LJ; Bissell MG
Clin Leadersh Manag Rev; 2004; 18(1):50-1. PubMed ID: 14968755
[No Abstract] [Full Text] [Related]
13. Europe to ban direct-to-consumer genetic tests?
Borry P
Nat Biotechnol; 2008 Jul; 26(7):736-7. PubMed ID: 18612288
[No Abstract] [Full Text] [Related]
14. DTC genetic services: a look across the pond.
Borry P; Howard H
Am J Bioeth; 2008 Jun; 8(6):14-6. PubMed ID: 18726773
[No Abstract] [Full Text] [Related]
15. Innovation, risk, and patient empowerment: the FDA-mandated withdrawal of 23andMe's Personal Genome Service.
Downing NS; Ross JS
JAMA; 2014 Feb; 311(8):793-4. PubMed ID: 24474248
[No Abstract] [Full Text] [Related]
16. Genome scans get personal with online consumer services.
Ann Neurol; 2008 Feb; 63(2):A15-7. PubMed ID: 18306396
[No Abstract] [Full Text] [Related]
17. Direct-to-consumer marketing of genetic tests for cancer: buyer beware.
Gray S; Olopade OI
J Clin Oncol; 2003 Sep; 21(17):3191-3. PubMed ID: 12874271
[No Abstract] [Full Text] [Related]
18. FDA halts sale of genetic test sold to consumers.
McCarthy M
BMJ; 2013 Nov; 347():f7126. PubMed ID: 24284347
[No Abstract] [Full Text] [Related]
19. Regulators weigh risks of consumer genetic tests.
Schmidt C
Nat Biotechnol; 2008 Feb; 26(2):145-6. PubMed ID: 18259159
[No Abstract] [Full Text] [Related]
20. Cost of genetic counseling and testing for BRCA1 and BRCA2 breast cancer susceptibility mutations.
Lawrence WF; Peshkin BN; Liang W; Isaacs C; Lerman C; Mandelblatt JS
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):475-81. PubMed ID: 11352857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
